mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.06 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.06 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.06 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.06 |
mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
0.059 |
0.06 |
mRNA |
GNF-2 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.06 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.06 |
mRNA |
Bosutinib |
GDSC1000 |
pan-cancer |
AAC |
0.063 |
0.06 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.07 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.07 |